Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Investigator Blinded Study of Protopic (Tacrolimus) Ointment Vs. Elidel (Pimecrolimus) Cream in Pediatric Patients With Moderate to Severe Atopic Dermatitis

NCT00666159 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00666159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Investigator Blinded Study of Protopic (Tacrolimus) Ointment Vs. Elidel (Pimecrolimus) Cream in Pediatric Patients With Moderate to Severe Atopic Dermatitis
Lead sponsor
Astellas Pharma Inc
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2002
Completion date
May 31, 2003
Enrollment
226 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.